Keratosis: all 347 studies
Page 3 of 4. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Cosmetic Study of AO+Mist in Improving the Appearance of Skin Afflicted With Keratosis PilarisCompletedNCT03243617Not applicable
- Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic KeratosisCompletedNCT03210740Phase 2
- Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin LesionCompletedNCT03127670Phase 2
- DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant RecipientsCompletedNCT03110159Phase 1/2
- Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOSCompletedNCT03076892Not applicable
- Phase 3 Study of Levulan With New Blue Light for AK on the Face or ScalpWithdrawnNCT03024060Phase 3
- Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field CancerizationStatus unknownNCT03013647Not applicable
- Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs CryotherapyCompletedNCT02990221Phase 4
- Menthol for PDT Pain ReliefCompletedNCT02984072Phase 4
- Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic KeratosisCompletedNCT02976727Phase 1
- Pilot Study of the Pragmatic Use of Mobile Phone Based Follow up of Actinic Keratoses Treated With Topical 5-fluorouracilCompletedNCT02938715Not applicable
- Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoCompletedNCT02902822Not applicable
- Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United StatesWithdrawnNCT02867722Not applicable
- Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / ResectionWithdrawnNCT02851693Not applicable
- A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its PrecursorsWithdrawnNCT02813902Phase 1
- A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic KeratosisCompletedNCT02799030Phase 2
- Using a Cold Atmospheric Plasma Device to Treat Skin DisordersStatus unknownNCT02759900Not applicable
- Tobacco Cessation Intervention Study for Oral DiseasesStatus unknownNCT02737176Not applicable
- Daylight-PDT With MAL for AK and Photodamaged SkinCompletedNCT02736760Phase 4
- Metvix Daylight PDT in Actinic KeratosisCompletedNCT02674048
- Efficacy of Iontophoresis-assisted AFL-PDT in Actinic KeratosisCompletedNCT02670655Phase 1
- A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 GelCompletedNCT02650505Phase 1
- Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA GelStatus unknownNCT02647151Phase 4
- Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation ProtocolCompletedNCT02644187Not applicable
- Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation TimesCompletedNCT02622594Phase 4
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald ScalpCompletedNCT02611804Phase 3
- Biological Effects of LEO 43204 in Actinic KeratosisCompletedNCT02600598Phase 1
- The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical PracticeCompletedNCT02594436
- Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic KeratosisCompletedNCT02559934Phase 1
- A Comparison of White-light and Daylight Topical Methyl 5-aminolaevulinic Acid Photodynamic Therapy for Actinic KeratosesCompletedNCT02520700Not applicable
- Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic KeratosesTerminatedNCT02473848Phase 3
- Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)CompletedNCT02464709Phase 4
- A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic TherapyCompletedNCT02451579Not applicable
- Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use ConditionsCompletedNCT02424305Phase 1
- PMS to Evaluate the Safety and Efficacy of Picato® GelCompletedNCT02421471
- Treatment of Actinic Keratoses (AK) on the FaceCompletedNCT02411851Phase 1
- Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or ScalpCompletedNCT02406014Phase 4
- Electrocautery vs Q-switch for Seborrheic KeratosisWithdrawnNCT02366559Not applicable
- The Real Life Topical Field Treatment of Actinic Keratosis StudyCompletedNCT02362152
- Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic KeratosisStatus unknownNCT02354391Phase 2
- Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar KeratosisCompletedNCT02352987Phase 2
- Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic KeratosisCompletedNCT02337205Phase 1
- Open Uncontrolled Validation Study for the German Version of the Actinic Keratosis Quality of Life Questionnaire (AKQoL)CompletedNCT02325661Not applicable
- Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic KeratosesCompletedNCT02289768Phase 3
- IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic KeratosisStatus unknownNCT02281682Phase 4
- Oral Isotretinoin Versus Topical Tretinoin for Actinic KeratosisCompletedNCT02278861Phase 2
- Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic KeratosisCompletedNCT02248298Phase 1
- Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic KeratosisCompletedNCT02242747Not applicable
- Twelve Month Follow-Up of CP0108CompletedNCT02209012
- Protocols for Painless Photodynamic Therapy (PDT) of Actinic KeratosesCompletedNCT02124733Phase 3
- Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use ConditionsCompletedNCT02124239Phase 1
- Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 WeeksCompletedNCT02090465
- Clinical Study Assessment of SR-T100 Topical Gel Against Actinic KeratosisCompletedNCT02085395Phase 2
- Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational VideoCompletedNCT02062853Not applicable
- Pharmacokinetic Study of Solamargine in Patients With Actinic KeratosisCompletedNCT02029066Phase 1
- Actinic Keratosis StudyCompletedNCT02019355Early Phase 1
- Effects of Topical Diclofenac on Tumor MetabolismCompletedNCT01935531Phase 4
- Evaluation of a Topical Treatment for Actinic KeratosisCompletedNCT01921907Phase 2
- Nanocytology Test to Evaluate Skin Cancer in High Risk PatientsCompletedNCT01905891Not applicable
- Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic KeratosesCompletedNCT01898936Not applicable
- Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%CompletedNCT01892137Phase 1
- Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and ScalpCompletedNCT01836367Phase 1
- Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the ForearmCompletedNCT01803477Phase 1/2
- Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.CompletedNCT01788007Phase 1
- Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic KeratosisCompletedNCT01757613Phase 2
- Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to ArsenicCompletedNCT01752972Not applicable
- Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer KeratosisCompletedNCT01748669Phase 2
- A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic KeratosisCompletedNCT01742663Phase 1
- Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin LesionsWithdrawnNCT01735942Early Phase 1
- Effect of Nigella Sativa in the Treatment of Palmer Arsenical KeratosisCompletedNCT01735097Not applicable
- Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical KeratosisCompletedNCT01731756Not applicable
- Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic KeratosisCompletedNCT01703078Phase 1
- Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic KeratosisStatus unknownNCT01656226Phase 4
- Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the HeadCompletedNCT01611480Phase 2
- Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis LesionsCompletedNCT01583816Phase 2
- Photodynamic Therapy of Actinic Keratoses With Alacare®CompletedNCT01571336
- Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant RecipientsTerminatedNCT01538901Phase 4
- Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic KeratosisCompletedNCT01516515Phase 2
- A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic KeratosesCompletedNCT01502020Not applicable
- Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis TreatmentCompletedNCT01493921Phase 3
- Comparative Study of Photodynamic Therapy vs. CO2 Laser Therapy in Treatment of Actinic KeratosesStatus unknownNCT01481155Not applicable
- Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis TreatmentCompletedNCT01459393Phase 3
- Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)CompletedNCT01453179Phase 4
- Development and Validation of a Quality of Life Instrument for Actinic KeratosisCompletedNCT01444989Not applicable
- Selenium in the Treatment of Arsenic Toxicity and CancersCompletedNCT01442727Phase 3
- Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic KeratosisStatus unknownNCT01413763Phase 4
- 5fluorouracil for Advanced PhotoagingStatus unknownNCT01405144Phase 3
- PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by HistologyCompletedNCT01387711Phase 1
- LAS41005 in Hyperkeratotic Actinic KeratosisCompletedNCT01358851Phase 2
- Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and PlaceboCompletedNCT01354717Phase 3
- PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy SubjectsCompletedNCT01302925Phase 1
- Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic KeratosisCompletedNCT01265602Phase 3
- Fractional CO2 Laser Assisted Photodynamic TherapyCompletedNCT01260987Phase 2/3
- Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic KeratosesStatus unknownNCT01229319Phase 4
- Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic KeratosisCompletedNCT01214564Phase 2
- Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?CompletedNCT01159860Not applicable
- Imiquimod and Actinic Keratoses: an Observational StudyCompletedNCT01151956
- Efficacy and Safety Study of LAS41007 in the Treatment of Actinic KeratosisCompletedNCT00991861Phase 2
- A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 StudyCompletedNCT00989313
- Study on the Efficacy of LAS41005 in the Treatment of Actinic KeratosisCompletedNCT00987246Phase 3